Pricing Log in Create free account

Achieve Life Sciences, Inc. (ACHV) vs 4D Molecular Therapeutics, Inc. (FDMT)

Achieve Life Sciences, Inc. and 4D Molecular Therapeutics, Inc. are both Biotechnology companies. Achieve Life Sciences, Inc. and 4D Molecular Therapeutics, Inc. are of similar size ($656.0M and $621.5M). 4D Molecular Therapeutics, Inc. grew revenue faster over the last twelve months: 278,712.1% against −5.58%. Achieve Life Sciences, Inc. has the higher net margin (0.00% vs −194.7%) and the higher return on invested capital (0.00% vs −186.9%). Across the 17 metrics below, 4D Molecular Therapeutics, Inc. leads on 10 and Achieve Life Sciences, Inc. on 7.

Valuation

Metric ACHV FDMT Biotechnology median
P/E n/m n/m 10.60
P/S 39.77 9.41 9.40
P/B n/m 2.12 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 28.97 5.70 9.02
Earnings yield (23.03%) (22.38%) (32.88%)
Free cash flow yield (7.48%) (18.01%) (23.13%)

Profitability

Metric ACHV FDMT Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (214.24%) 0.00%
Net margin 0.00% (194.74%) 0.00%
Free cash flow margin 0.00% (169.51%) 0.00%
Return on equity (844.99%) (43.25%) (51.96%)
Return on assets (91.46%) (37.09%) (46.06%)
Return on invested capital 0.00% (186.91%) 0.00%

Growth

Metric ACHV FDMT Biotechnology median
Revenue growth (TTM) (5.58%) 278,712.12% 6.76%
EPS growth (last fiscal year) (0.81%) 18.79% 29.88%
Revenue growth, 5-year CAGR (17.95%) 44.32% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACHV FDMT Biotechnology median
Debt to equity (1.11) 0.05 0.00
Current ratio 0.95 8.03 4.97
Net debt to EBITDA 0.36 2.52 1.01

Dividend

Metric ACHV FDMT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACHV FDMT Biotechnology median
Market cap 656.00m 621.50m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack